Rasagiline
CAS 136236-51-6
Visão geral
Rasagiline is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H
A Anant Labs fabrica e fornece impurezas de Rasagiline de alta qualidade para o mercado global. Nossas impurezas EP de Rasagiline são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.
Dados Técnicos
CAS136236-51-6
Fórmula Mol.C12H13N
Peso Mol.171.243 g/mol
IUPAC(1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amine
SMILESC#CCN[C@@H]1CCC2=CC=CC=C12
InChIInChI=1S/C12H13N/c1-2-9-13-12-8-7-10-5-3-4-6-11(10)12/h1,3-6,12-13H,7-9H2/t12-/m1/s1
Chave InChIRUOKEQAAGRXIBM-GFCCVEGCSA-N
Note: We are upgrading our system, Cat No will change.
Sinônimos
rasagiline136236-51-6(R)-N-2-Propynyl-1-indanamineTV-1030Rasagilina(1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amineNSC-759639(1R)-N-propargylindan-1-amine003N66TS6T(R)-Indan-1-yl-prop-2-ynyl-amine
